Corient Capital Partners’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$273K Hold
7,560
0.02% 493
2022
Q2
$273K Sell
7,560
-473
-6% -$19.6K 0.02% 504
2022
Q1
$394K Buy
8,033
+784
+11% +$39.7K 0.03% 440
2021
Q4
$347K Sell
7,249
-20
-0.3% -$947 0.02% 468
2021
Q3
$319K Buy
7,269
+60
+0.8% +$2.54K 0.02% 474
2021
Q2
$316K Buy
7,209
+37
+0.5% +$1.74K 0.02% 479
2021
Q1
$328K Buy
7,172
+8
+0.1% +$335 0.03% 423
2020
Q4
$231K Buy
+7,164
New +$207K 0.02% 446

Other funds holding SNV

Corient Capital Partners's SNV Position: Q3 2022 in Review

Corient Capital Partners held its Synovus (SNV) position steady in Q3 2022 at 7,560 shares worth $273K. The position accounts for 0.02% of the portfolio, ranked #493.

Corient Capital Partners first reported a position in SNV in Q4 2020 and has held it in 8 quarters since. The position peaked at $394K in Q1 2022. 406 funds tracked by Wall St. Rank hold SNV as of Q3 2022.

  • Corient Capital Partners held 7,560 shares of Synovus worth $273K as of Q3 2022.
  • Corient Capital Partners left its Synovus share count unchanged in Q3 2022.
  • Synovus made up 0.02% of Corient Capital Partners's portfolio in Q3 2022, its #493 holding.
  • Corient Capital Partners first reported a position in Synovus in Q4 2020 and has held it in 8 quarters since.
  • Corient Capital Partners's Synovus position peaked at $394K in Q1 2022.
  • 406 funds tracked by Wall St. Rank held Synovus as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.